Abstract:Introduction: A major requirement in bone tissue engineering is the persistent and robust promotion of osteogenesis, which requires sustained stimulation with osteoinductive factors, such as bone morphogenetic protein-2 (BMP-2). However, the direct application of these factors remains challenging due to their short half-life and rapid systemic clearance. Given the well demonstrated benefits of recombinant adeno-associated viral (rAAV) vector, including long-term gene transfer efficiency and relative safety, rAAV-based therapies have been developed in both basic and translational research. However, traditional ex vivo gene transduction process is time consuming and requires multiple steps of cell culture. In addition, rAAV shows inconsistent transfection efficacy in primary cells. In this study, we co-packed rAAV-BMP-2 and human bone marrow stem cells (hBMSCs) into a gelatin scaffolds through one-step visible light-based phtocorsslinking (PXL), and tested their application for bone regenerationi. We hypothesize that the concentrated and localized release of rAAV-BMP-2 from the scaffold matrix results in higher transfection efficacy and BMP-2 expression in hBMSCs seeded within the scaffolds, thus enhancing their osteogenic differentiation and bone formation upon implantation in bone defect. Methods: hBMSCs were obtained with IRB approval from total joint arthroplasty patient. The rAAV6-BMP-2 and rAAV6-GFP reporter (as control) vectors were designed and prepared using an established protocol in our laboratory. PXL was performed using 10% gelatin and 10×106 hBMSCs/ml with different amount of rAAV6-GFP. Transfection efficiency was determined by counting GFP-positive cells ratio as well as assessing cell viability. At an optimal ratio, rAAV-BMP-2 and hBMSCs were included into gelatin through PXL. At different time point, BMP-2 production and rAAV6 release kinetics were analyzed. The osteogenesis of hBMSCs was assessed at day 28 by real time PCR and histological staining. In animal study, a 0.5 cm diameter critical size of cranial bone defect model was generated in SCID mice and then the constructs described above were transplanted. Micro-CT imaging and histological staining were used to evaluate the skull bone healing process up to 6 weeks. Results: Both rAAV and hBMSCs survived during the scaffold fabrication process. 10×104 rAAV/hBMSCs was shown to be the optimal ratio in maintaining cell viability and achieving transduction efficiency. After in situ transfection within scaffolds, hBMSCs produced higher BMP-2 amount than those subjected to traditional ex vivo transduction process, and underwent robust osteogenesis as well. In animal study, micro-CT imaging results indicated that rAAV BMP-2 & hBMSCs-activated gelatin scaffolds effectively promoted bone regeneration in mice cranial bone defect, in a manner significantly superior to that of scaffolds loaded with hBMSCs/BMP-2 protein, and was remarkably compatible to scaffolds loaded with hBMSCs previously ex vivo transduced by rAAV-BMP-2. The histological staining further confirmed the efficacious bone formation from rAAV BMP-2 & hBMSCs loaded scaffold. The results shown here thus demonstrate the feasibility of combining gene and cell therapy with biomaterial engineering via a single-step fabrication and its application for the repair of bone defect.

TRANSFECTION OF HMSCS WITH CHEMICALLY MODIFIED MRNA CODING FOR BMP-7 ENHANCES OSTEOGENESIS

Highly efficient healing of critical sized articular cartilage defect in situ using a chemically nucleoside-modified mRNA-enhanced cell therapy

Demineralized Bone Matrix Scaffold Modified with Mrna Derived from Osteogenically Pre-Differentiated MSCs Improves Bone Repair.

[Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cell after Transfection with Recombinant Pad-Bone Morphogenetic Protein-7].

524. Injectable BMP-2 Gene-Activated Scaffold for the Repair of Mouse Cranial Bone Defect

[Effects of Transient Transfection of Human BMP-4 Gene on Rabbit Bone Marrow Stromal Cells].

BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways

Enhanced Osteogenic Activity of Mesenchymal Stem Cells and Co-Modified BMP-2 and Bfgf Genes.

BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential.

Bone Morphogenetic Protein-7 Induces Chondrogenic Differentiation in Human Mesenchymal Stem Cells Cultured on Tricalcium Phosphate-Collagen Scaffolds

Innovative Strategy for 3D Transfection of Primary Human Stem Cells with BMP-2 Expressing Plasmid DNA: A Clinically Translatable Strategy for Ex Vivo Gene Therapy

The Osteogenic Potential of Stem Cell- and Bmp2 Gene-Activating Bioceramic in Vivo

Mesenchymal Stem Cell-Derived Microvesicles Mediate BMP2 Gene Delivery and Enhance Bone Regeneration.

Effects of Perfusion , Cyclic Compression and Bone Morphogenetic Protein-7 on the Proliferation and Differentiation of Human Bone Marrow Stromal Cells Seeded on the Polyurethane Scaffolds

Effective delivery of bone morphogenetic protein 2 gene using chitosan–polyethylenimine nanoparticle to promote bone formation

Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.

Human bone morphogenetic protein 7 gene transfection for the proliferation and osteogenetic differentiation of the bone marrow mesenchymal stem cells

[EXPERIMENTAL STUDY ON TISSUE ENGINEERED BONES CONSTRUCTED BY HUMAN BONE MORPHOGENETIC PROTEIN 2 GENE-MODIFIED HUMAN BONE MARROW MESENCHYMAL STEM CELLS].

Synergistic effect of recombinant human bone morphogenic protein-7 and osteogenic differentiation medium on human bone-marrow-derived mesenchymal stem cells in vitro

A Thermoresponsive Polydiolcitrate-Gelatin Scaffold and Delivery System Mediates Effective Bone Formation from BMP9-transduced Mesenchymal Stem Cells

The Gene Expression Patterns of Bone-marrow Mesenchymal Stem Cells under Different Osteogenic Induction